DOCSLIB.ORG

AAHP-Summit-Brochure

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
AAHP-Summit-Brochure AAHP_Program_11x17_Final6:Layout 1 6/25/19 2:37 PM Page 1 Proudly celebrating 25 years as your strategic partner for accelerating mid-market brand growth. We manage a $4 billion HBC portfolio which provides the scale to efficiently leverage trends and insights in the development of category-leading growth plans for our clients. Over the past three years, the Emerson Group portfolio has grown 1.7X the HBC category. Expert Sales Leadership Category Management The Emerson Group Strategic Sales Planning Shopper Insights & Analytics 1994 Brand & Shopper Marketing E-Commerce Strategy & Management SummitSummit onon Sales Operations Infrastructure Comprehensive Syndicated Data 2019 ChallengesChallenges && SolutionsSolutions For additional information about the advantages of the Emerson Group call Roger Gravitte at 610.971.9600 inin QualityQuality && SafetySafety www.emersongroup.com We’re glad you’re here. ofof HomeopathicHomeopathic DrugDrug ProductsProducts 99 a.m.–5a.m.–5 p.m.,p.m., Friday,Friday, JuneJune 28,28, 20192019 HiltonHilton BaltimoreBaltimore #SafetySummit#SafetySummit #Homeopathy#Homeopathy AAHP_Program_11x17_Final6:Layout 1 6/25/19 2:37 PM Page 3 Welcome to the AAHP Summit Nelson Bach USA Ltd. Terravitals R • Carol Wasteneys, Regulatory and Quality Mgr. • Navid Pezeshkzad, Homeopathic Consultant • Denise Eaton, Bach Brand/Education Mgr. Welcome to the AAHP Summit! The Summit was designed specifically for • John Ende, General Manager The Emerson Group homeopathic manufacturers and our special challenges with high dilutions. • Scott Emerson Everyone in this room should be congratulated as a leader in the industry by OHM Pharma, Inc. coming together for an open exchange to solve our challenges. • Justyna Mazur, Dir., Regulatory Compliance • Robert Melo, President The Markens Group • Brian Westerlind, Communications Manager Procter & Gamble We have a responsibility to produce products of the highest quality so that consumers • Emily Leonczyk, Director of Marketing • Adrian Land and families across the U.S. and the world receive the full health benefits of homeopathy without safety risks or questionable reliability. To all the quality and Propulsora de Homeopatia TRP Company regulatory staff here today with their top management, this should be your • Javier Lopez • Stephen Pike, Supply Chain Strategist everyday mission: To minimize risk by manufacturing based on sound quality and • Jesus Navarro, CEO U.S. Food and Drug Administration safety principles. RB Health • Francis Godwin, Director, OMQ • Donna Alvarez, Senior Regulatory Associate • Elizabeth Kelley, Regulatory Counsel AAHP has assembled the highest quality information on these topics in a format Racher Press (Chain Drug Review) • Tamara Ely, Consumer Safety Officer that is responsive to attendees needs and regulators expectations. Please make the • Andrea Fallin, Director most of this opportunity. Our discussions here will affect the future, providing • Mark Baumgartner, Senior Editor Van Scoyoc Associates retailers, practitioners and consumers better, safer, reliable products for their Similasan Corp • Pete Evich, Vice President wellbeing. • Dan Quail, President • Kimberly Stark, Dir., Quality & Regulatory Affairs Washington Homeopathic Products • Yann Pigeaire, Vice President, Marketing • Belle Noorzai, Dir., Sales & Marketing Standard Homeopathic/Hyland's • Linda Lillard, President • Alison McPeak, Manager, Pharmacy • Wais Noorzai, Quality Assurance Manager • Jay Borneman, CEO Mark Land • Les Hamilton, President Wegmans Food Market, Inc. AAHP President • Mary Borneman, Sr. Dir., Comm. & Public Affairs • Katie Niles, Healthcare Category Merchant • Eric Baier, Sr. V.P., Regulatory & Technical Affairs • Karen Shadders, V.P., Health, Wellness, Home & Entertaining • John Karl Schlottig, Director of Process Validation • Mark Phillips, Vice Chairman Weleda, Inc. • Stephen Reta, Regulatory Affairs Manager • Petra Augenstein Tec Labs • Mary Cha, Regulatory Affairs Whole Foods Market • Nikki Frum • Lee Mayberry, Global Legal Regulatory Coordinator Thank You 2019 AAHP Board of Directors! President - Mark Land, Boiron USA Treasurer - Mark Phillips, Standard Homeopathic/Hyland's Secretary - Eric Foxman, Eric L. Foxman Consulting Members of the Board Travis Borchardt, Nature’s Way Mary Borneman, Standard Homeopathic/Hyland's Denise Eaton, Nelson Bach USA Ltd. Guillaume Lois, HBC Naturals Dan Quail, Similasan Corp Mary Beth Watkins, Emeritus AAHP_Program_11x17_Final6:Layout 1 6/25/19 2:37 PM Page 5 Attendees of the AAHP Reception and Summit Opening Keynote: Francis Godwin, MBA, Director, Office of Manufacturing Quality, AmerisourceBergen Homeopet Office of Compliance, Center for Drug Evaluation and Research, • Doug Trueman, V.P., Consumer Products • Aindriu Farrington • Jim Beck, Director • Ingrid Semino, Supply Chain Manager U.S. Food and Drug Administration After receiving his undergraduate degree from MIT in Chemical Engineering in 2001, Francis Godwin worked Informa (Pink Sheet and HBW Insight) Boiron as a process engineer designing, building, and optimizing chemical plants. In 2009 he received an MBA from • Eileen Francis, Reporter • Alissa Gould, Dir., Corp. Comm. & Public Affairs Georgetown University and since then, has been working at FDA in CDER's Office of Compliance. Francis has • Malcolm Spicer, Consumer Health Writer • Fanny Guillot, Manager, Regulatory Affairs served in various functions within compliance, and is currently the Director of the Office of Manufacturing • Gary Wittenberg, V.P., National Accounts Little Big Brands Quality, overseeing regulatory and enforcement actions for both foreign and domestic drug CGMP cases. • Janick Boudazin, President & CEO • Katie Littlefield, Business Development Acc. Dir. • Katie Lopez, Account Director • Kristina Skowronek, Dir., Quality & Regulatory Compliance AAHP Inaugural Industry Reception • Mark Land, V.P., Government & Regulatory Affairs Lorman Law DC • MaryEllen Tefft, Director of Sales-FDM • Al Lorman 5–7 p.m., Thursday, June 27 • Melissa Boyle, Regulatory Administrative Specialist MAI Consulting, Inc. Hilton Baltimore Carroll Room overlooking Camden Yards • Ray Petrick, Vice President of Sales • George Bernstein, President • Scott Bradley, Regional Account Manager, Mid-Atlantic AAHP’s special evening reception celebrates its inaugural Summit with senior executives from the homeopathic industry and other special • Jan Owens guests. Remarks from thought leaders include: • Scott Osborne, Dir., Strategic Account Development • Stacey Kelly, Quality Assurance Manager Matrixx Initiatives • Stephanie Chanut, Analytical Methods Dev. Lab. Mgr. • Arlene Ascarate, Director of R&D • Public Policy; What We Have Learned • John Clayton, Regulatory Consultant Scott M. Melville is President and CEO of the Consumer Healthcare Products Association. He leads CHPA’s Brandperx • Lou Fraser, Director of Quality Assurance efforts to preserve and expand choice and availability of consumer healthcare products. He was previously • Mark Collins, National Account Director • Tim Clarot, Sr., V.P., R&D and Product Quality SVP of government affairs and general counsel for the Healthcare Distribution Alliance, has held public Medinatura Inc. affairs and legal roles for Sterling-Winthrop, Hoffmann-LaRoche, and Cephalon, and has been a legislative Coelus, LLC assistant for a Member of Congress. He earned his bachelor’s degree in economics and political science • Cathy Raish, V.P., Regulatory/Quality • Matthew Reed, Principal from Bucknell University, and his juris doctorate from George Mason University. • Elena Elliott-Hind, QC Lab Manager Consumer Healthcare Products Association Miers Laboratories • Barbara Kochanowski, Sr., V.P., Regulatory & Scientific Affairs • Andrew Criglington • Jay Sirois, Sr. Dir., Regulatory & Scientific Affairs • Michael Dong • Business Report: State of the Homeopathic Retail Industry • Scott Melville, President & CEO Scott R. Emerson. Mr. Emerson is the founder and CEO of The Emerson Group and its subsidiaries, Emerson Morgan Lewis & Bockuis Healthcare and Emerson Marketing. The Emerson Group is a forward-thinking consumer products equity CPG Linkages, LLC • Ann Begley, Partner organization which manages CPG brands in excess of $4 billion, and holds equity positions with small and medium- • Ted Peterson, President size brands. (See sponsor section for company information.) Mr. Emerson has over 30 years’ experience with Nartexlabs companies including Johnson & Johnson, Unilever and Novartis Consumer Health. Prior to founding the Emerson • Eduardo Acosta, CEO Customer Marketing Group Group, he has held senior management positions in Fortune 500 companies within brand management, • Bruce Montgomery, General Manager National Association of Chain Drug Stores new business development, sales operations and field sales. He received his B.A. in Accounting and Business Management from Texas State University. ECRM • Jim Whitman, Sr., V.P., Member Programs & Services • Wayne Bennet, Sr., V.P., Retail National Center for Homeopathy Board of Directors • Presentation of AAHP Interactive Medicine Award to Wegmans Food Markets, Inc., and remarks from • Abby Beale, Past-president Eric L. Foxman Consulting recipient Karen Shadders, Vice President, Health, Wellness, Home & Entertaining. The award recognizes a • Christina Donka, Board Member retailer that promotes and sells products that encompass a broad range of therapeutic approaches to • Eric Foxman, AAHP Secretary • Deb Dupnik, Executive Director achieve optimal health and wellness
Load more

Recommended publications
  • Show Me the Research 2014
    Show me the research By ©Elena Cecchetto 2015 Homeopathy has a long history of popular use (hundreds of years). It also has a history of being criticized in North America where the medical industry is dominated by the pharmaceutical industry. Homeopathy is second only to Jesus as the two most controversial topics according to Wikipedia.1 Considering my previous career in political advocacy focusing on environmental and conservation issues, I sometimes ask myself; Is that what attracted me to homeopathy? No! It was the fact that once I gave it a try for my lifetime struggle with de-habilitating eczema, it did something that nothing else could do for me and so I was ecstatic.2 That success indeed was what made me passionate about ensuring that people know about homeopathy as an option if they so choose. Unfortunately, that passion has led me here – writing to justify the amazing healing that I am now able to do for many others, now that I’ve spent over ten years continuing to study all aspects of homeopathy above and beyond my four year diploma requirement in order to call myself a homeopathic practitioner.3 Luckily I now have access to University level databases of research publications without having to pay the download fees. You, reading this are lucky too, because I am writing to share this with you. I have been reticent to spend the time to put this type of information out there before now because I realize that there is no way that this article written by a homeopath will ever change the minds of anyone who is bothering to put all their wasted energy in trying to discredit homeopathy.
    [Show full text]
  • RELIABILITY of HOMEOPATHIC MEDICINE an ESSENTIAL REQUIREMENT Behind Every Boiron Medicine, There Is a Patient Who Trusts Us
    RELIABILITY OF HOMEOPATHIC MEDICINE AN ESSENTIAL REQUIREMENT Behind every Boiron medicine, there is a patient who trusts us. Every Boiron partner is guided by this statement. It’s what we pride ourselves on. — 3 — We know your requirements. We share them. Doctors, pharmacists, laboratories: each in our own way, we contribute to the health of patients. As a laboratory, our commitment, first and foremost, is to guarantee that our homeopathic medicines are reliable and of high-quality. From this perspective, having our own equipment to produce all of our medicines ourselves demonstrates our willingness to master the manufacturing process in its entirety. Constantly striving to do better, the 141 Boiron pharmacists and the entire production team monitor the quality of our medicines on a daily basis. With rigour and professionalism, they focus on promoting excellence by routinely combining tradition and innovation. Our commitment: to allow you to rest assured that Boiron homeopathic medicines are reliable as well as beneficial to your practice and to the health of your patients. Jean-Christophe Bayssat, Deputy General Manager, Responsible Pharmacist — 3 — GUARANTEEING THE QUALITY OF THE RAW MATERIALS MASTERING THE SPECIFIC FEATURES OF A UNIQUE MEDICINE Ensuring consistent quality of the substances used E Our homeopathic medicines are produced from For instance, our plants undergo a triple control Strains of varied substances of varying origin using a dynamic screening. origin dilution process. Organoleptic: to ensure that the batch received is healthy To identify and collect these raw materials, (no disease or aphids) and clean (free from Boiron surrounds itself with qualified foreign matter).
    [Show full text]
  • Homeopathic Oscillococcinum(R)
    Homeopathic Oscillococcinum® for preventing and treating influenza and influenza-like illness (Review) Mathie RT, Frye J, Fisher P This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2015, Issue 1 http://www.thecochranelibrary.com Homeopathic Oscillococcinum® for preventing and treating influenza and influenza-like illness (Review) Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 PLAINLANGUAGESUMMARY . 2 SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . ..... 3 BACKGROUND .................................... 4 OBJECTIVES ..................................... 5 METHODS ...................................... 5 RESULTS....................................... 7 Figure1. ..................................... 9 Figure2. ..................................... 11 Figure3. ..................................... 11 Figure4. ..................................... 12 Figure5. ..................................... 13 Figure6. ..................................... 13 DISCUSSION ..................................... 13 AUTHORS’CONCLUSIONS . 15 ACKNOWLEDGEMENTS . 16 REFERENCES ..................................... 16 CHARACTERISTICSOFSTUDIES . 19 DATAANDANALYSES. 27 Analysis 1.1. Comparison 1 Prevention: Oscillococcinum versus placebo, Outcome 1 Occurrence of influenza-like illness. 28 Analysis 2.1. Comparison 2 Treatment: Oscillococcinum
    [Show full text]
  • Taking the Case of Homeopathy Juliet Louise
    PRACTITIONER BASED INQUIRY: TAKING THE CASE OF HOMEOPATHY JULIET LOUISE SMITH A thesis submitted in partial fulfilment of the requirements of Bournemouth University for the degree of Doctor of Philosophy Bournemouth University January 2012 This copy of the thesis has been supplied on condition that anyone who consults it is understood to recognise that its copyright rests with its author and due acknowledgement must always be made of the use of any material contained in, or derived from, this thesis. ABSTRACT JULIET L SMITH PRACTITIONER BASED INQUIRY: TAKING THE CASE OF HOMEOPATHY After twenty years of practising and teaching homeopathy, I am concerned that research into treatment by professional homeopaths has become stifled by evidence based medicine discourse. Homeopathy’s distinguishing features are obscured by erroneous assumptions that a homeopathic prescription is subject to the same biochemical pathways as pharmacological medication. Homeopaths are urged by external parties to ‘prove homeopathy works’ on biomedical terms. This reflexive inquiry is an attempt to redress the balance. From postmodern and pragmatic perspectives I reflexively engage with professional experiences (Smith, 2009) as a means of articulating practitioner based knowledge (Freshwater and Rolfe, 2001, Rolfe et al., 2001). The subjectivity of the practitioner researcher is transformed from a research problem into an opportunity to critically examine practitioner experience (Lees and Freshwater, 2008). The research process is a focus for the inquiry itself, with the intention of creating an open text that invites participation from the reader (Denzin and Lincoln, 1994). I ‘take the case’ of my own practice and its wider context, and enact a synergy of homeopathic practice and research methodologies.
    [Show full text]
  • SPONSOR OPPORTUNITY Invest in the Research for a Homeopathic Vaccination
    SPONSOR OPPORTUNITY Invest in the research for a Homeopathic Vaccination By Roy Martina M.D., st developer of the 1 ​ homeopathic vaccination. ​ Green Big Pharma is a company with a mission to help people with natural research and proven remedies to restore health & speed up recovery. 1 Introduction: Where are we with vaccinations for COVID-19? 3 Australia starts by testing 2 potential vaccines 3 About Dr. Roy Martina 4 Introduction to Homeopathy 4 The Controversy Surrounding Homeopathic Remedies 4 What is Homeopathy? 5 The 5 Phases of COVID-19 This is how Dr. Martina looks at the COVID-19 different stages of infection. 5 Homeopathic Vaccinations: Introduction It’s going to take a lot longer to make a COVID-19 vaccine than a treatment. 6 Vaccines in General and Side Effects 6 Homeopathic Vaccination is Different 7 COVID19 Anti-Viral Support 8 Preparing your body in 3 ways 10 How to use 10 What is offered to potential Sponsors? 12 Addendum Research of Homeopathic Vaccinations 13 Scientific Proof of Homeopathic Vaccinations 13 Clinical Research On Homeoprophylaxis: 13 2 Introduction: Where are we with vaccinations for COVID-19? Australia starts by testing 2 potential vaccines Australian scientists announced Thursday (April 2nd) that the country's national science agency has started the first stage of testing for two potential Coronavirus vaccines, including one made by a U.S. company. The two trials have been cleared for animal testing by the World Health Organization, but scientists caution any vaccine likely wouldn’t be ready until late 2021, BBC News reported. Most Optimistic Scenario: 12-18 months “We’re still sticking to the optimistic 18 months for delivery of vaccine to the general consumers,” Rob Grenfell, the Commonwealth Scientific and Industrial Research Organization’s (CSIRO) director of health, told Reuters.
    [Show full text]
  • Homeopathic Dilutions of Mercury Chloride As an Effective And
    Journal of Surgery and Surgical Case Reports ISSN: 2694-4944 Review Article Homeopathic Dilutions of Mercury Chloride as an Ef- fective and Affordable Treatment for SARS-CoV-2 Masshiro Tamijia1*, Helmuth Putzenstofenb2, Cippa Lippaa1 and Guido Pancaldic3 1Inchiki Institute, Japan 2Department of Homeopathy, School of Medical Science, Germany 3Department of Quantum Molecular Science, University of Bugliano, Italy Abstract As of June 12, 2020, Corona Virus Disease 2019 (COVID-19) has been confirmed in 602,214 people worldwide, carrying a mortality of approximately 2.7415%. Current management of COVID-19 is supportive, and respiratory failure from Acute Respiratory Distress Syndrome (ARDS) is the leading cause of mortality. Indian government has recently revealed their plan for using homeopathic remedies as their leading treatment against COVID-19 infections. This work reveals that mercury containing solutions might have the highest effect against SARS-CoV-2, especially at really low concentrations. It has been also postulated that the homeopathic mercury dilutions can be activated by the presence of electromagnetic and natural bio-energetic fields and a strong correlation was found between the antiviral effects of mercury and the distance of an electromagnetic device (mobile phone). Keywords: Homeopathy; Mercury; Toxicity; Antiviral; Covid-19 Introduction global spread of COVID-19, effective interventions for severe cases of COVID-19 are urgently required [6]. According to the current A novel human corona virus that is now named Severe Acute clinical guideline in China and the experiences in the treatment of Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) (formerly SARS or Middle East Respiratory Syndrome (MERS) patients, both called HCoV-19) emerged in Wuhan, China, in late 2019 and is now conventional medicine and Traditional Chinese Medicine (TCM) causing a pandemic [1].
    [Show full text]
  • A Day in the Life
    NEWS FEATURE A day in the life Landmark conference ‘New Horizons in Water Science: Evidence for Homeopathy?’ (with apologies to J Lennon & P McCartney) by Lionel Milgrom PhD MARH RHom and Dana Ullman MPH CCH Foreword Some people not only have good ideas, but are also prepared to work hard to bring those ideas into fruition. Ken (or Lord Aaron Kenneth Ward Atherton, to give him his proper title) is one such person. He decided that we all needed a strong antidote to the ‘no evidence’ claims so frequently vaunted by the anti-homeopathy campaigners, and he organised a truly unforgettable one-day event (held at the Royal Society of Medicine, London), to remind us that Lionel (LRM) has been a homeopath for ‘proper’ science can be fascinating, inspiring and truly uplifting. over 20 years, training at the now defunct Ken’s impressive line-up of presenters were all internationally re- London College of Homeopathy, and the nowned scientists, including two Nobel laureates, and the theme Orion course in advanced homeopathy. He of the event was to explore the science underpinning our knowledge works from home now but has laboured of water structures. I came away from the day feeling really positive; at Nelsons, Ainsworths, and an integrated our emerging understanding of the science of water structures may dental practice in London’s West End. He is well lead us to eventually being able to explain how homeopathy also a scientist (chemist; co-founding an can work at a purely energetic level. On behalf of Team ARH and anticancer biotech spinout company), the rest of the homeopathy community, I would like to thank Ken a science writer, and in his latest incarna- for having the determination, perseverance and, above all, the vision tion, a chemistry teacher.
    [Show full text]
  • Homeopathic Pharmacy (Second Edition): Theory and Practice
    An imprint of Elsevier Limited © Pearson Professional Limited 1997 © 2006, Elsevier Ltd. All rights reserved The right of Steven B. Kayne to be identified as the author of this work has been asserted in accordance with the Copyright, Designs and Patents Act 1988. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the Publishers. Permissions may be sought directly from Elsevier’s Health Sciences Rights Department, 1600 John F. Kennedy Boulevard, Suite 1800, Philadelphia, PA 19103-2899, USA: phone: (+1) 215 239 3804; fax: (+1) 215 239 3805; or, e-mail: [email protected]. You may also complete your request on-line via the Elsevier homepage (http://www.elsevier.com), by selecting ‘Support and contact’ and then ‘Copyright and Permission’. First edition 1997 Second edition 2006 ISBN 0 443 10160 4 British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library. Library of Congress Cataloging in Publication Data A catalog record for this book is available from the Library of Congress. Note Knowledge and best practice in this field are constantly changing. As new research and experience broaden our knowledge, changes in practice, treatment and drug therapy may become necessary or appropriate. Readers are advised to check the most current information provided (i) on procedures featured or (ii) by the manufacturer of each product to be administered, to verify the recommended dose or formula, the method and duration of administration, and contraindications.
    [Show full text]
  • 1 Homeopathy: Mere Placebo Or Great Medicine? Post-‐Debate Questions I
    1 Homeopathy: Mere Placebo or Great Medicine? Post-Debate Questions I- Questions for André: A) Questions from Joe to André: 1-Homeopaths claim that even after a substance is dissolved in water or alcohol and diluted to such an extent that there is not a single molecule of the original solute left, the solution still retains some memory of the solute. But this solution is then impregnated into a sugar pill and the water is evaporated. What then is left behind? And how does whatever is left behind have anything to do with healing? A: Homeopaths are actually not making such a claim, but have instead been reporting a series of very important experimental observations that are, first, sick people are sensitive to remedies that can produce a similar state as their sickness;1 second, patients usually experience an initial aggravation when remedies are precisely prescribed to them according to this principle of similarity;2 third, to avoid this initial aggravation, Hahnemann did what any logical physician would do, he diminished the dose. At first, he used simple dilutions,3 and only many years later he began using serial succussed dilutions,4 a process he had previously used in chemistry5 and which had 1 Hahnemann reported this phenomenon in great detail and with many observations in 1796 in his Essay on a New Principle for Ascertaining the Curative Powers of Drugs. (In The Lesser Writings of Samuel Hahnemann. Collected and translated by R. E. Dudgeon. New York: William Radde, 1852: 249-303.) He confirmed this phenomenon during the 1799 scarlet fever epidemic in an article entitled On the Power of Small Doses of Medicine in General and of Belladonna in Particular.
    [Show full text]
  • Evidence Check 2: Homeopathy
    House of Commons Science and Technology Committee Evidence Check 2: Homeopathy Fourth Report of Session 2009–10 HC 45 House of Commons Science and Technology Committee Evidence Check 2: Homeopathy Fourth Report of Session 2009–10 Report, together with formal minutes, oral and written evidence Ordered by the House of Commons to be printed 8 February 2010 HC 45 Published on 22 February 2010 by authority of the House of Commons London: The Stationery Office Limited £0.00 The Science and Technology Committee The Science and Technology Committee is appointed by the House of Commons to examine the expenditure, administration and policy of the Government Office for Science. Under arrangements agreed by the House on 25 June 2009 the Science and Technology Committee was established on 1 October 2009 with the same membership and Chairman as the former Innovation, Universities, Science and Skills Committee and its proceedings were deemed to have been in respect of the Science and Technology Committee. Current membership Mr Phil Willis (Liberal Democrat, Harrogate and Knaresborough)(Chairman) Dr Roberta Blackman-Woods (Labour, City of Durham) Mr Tim Boswell (Conservative, Daventry) Mr Ian Cawsey (Labour, Brigg & Goole) Mrs Nadine Dorries (Conservative, Mid Bedfordshire) Dr Evan Harris (Liberal Democrat, Oxford West & Abingdon) Dr Brian Iddon (Labour, Bolton South East) Mr Gordon Marsden (Labour, Blackpool South) Dr Doug Naysmith (Labour, Bristol North West) Dr Bob Spink (Independent, Castle Point) Ian Stewart (Labour, Eccles) Graham Stringer (Labour, Manchester, Blackley) Dr Desmond Turner (Labour, Brighton Kemptown) Mr Rob Wilson (Conservative, Reading East) Powers The Committee is one of the departmental Select Committees, the powers of which are set out in House of Commons Standing Orders, principally in SO No.152.
    [Show full text]
  • Homeopathy and Allied Therapies
    Guest Contribution HOMEOPATHY AND ALLIED THER APIES: A REVIEW Everaldo Attard Institute of Earth Systems, Division of Rural Science and Food Systems, University of Malta, Msida, Malta. Corresponding author: Everaldo Attard, email: [email protected] Abstr act Introduction Following Dr Hahnemann’s evaluation and establishment Homeopathy is the basis of several forms of therapies of homeopathic medicine as an alternative medicine, that emerged later on throughout Europe. Homeopathy several other physicians and healthcare professionals and these related therapies form part of Europe’s applied the principles of homeopathy to different extents traditional medical history. Several physicians followed in order to develop other forms of therapies, according Hahnemann’s principles and applied them to their forms to their understanding of homeopathy. Homeopathy and of therapies. Such therapies include anthroposophic allied therapies evolved mainly in Germany, the United medicine, gemmotherapy, lithotherapy, organotherapy, Kingdom, France and Belgium. Some of these therapies Bach’s floral remedies, Schüssler’s tissue salts. However, are not considered as purely homeopathic by the in the multicultural and modern Europe, there is still a different countries. Such therapies include antroposophic long way for the official recognition and harmonisation medicine, gemmotherapy, lithotherapy, organotherapy, of products within the European Union Member States. Bach’s floral remedies and Schüssler’s tissue salt therapies. Due to popularity of these remedies with EU citizens, the Table 1 represents the different forms of therapies, their European centralised body and individual Member States originators, the period of establishment and traditional medicines authorities are obliged to safeguard the general origins. public through the assessment of safety and quality of these medicinal products.
    [Show full text]
  • Oscillo® Home
    Oscillo: Flu-Like Symptoms* - visited on 8/28/2017 Page 1 of 4 Oscillo® Home Oscillo® SKU: OSCILLOCOCCINUM. From $15.99 Uses* ◾ Reduces the duration and severity of flu-like symptoms such as body aches, headache, fever, chills and fatigue* ◾ Non-drowsy; No known drug interactions ◾ For everyone ages 2 and up ◾ Sweet-tasting, quick-dissolving pellets ◾ Help your body the natural way ◾ Available in a box of 6, 12 or 30 doses *These “Uses” have not been evaluated by the Food and Drug Administration. Doses Choose an option https://shop.boironusa.com/medicine/oscillococcinum/ 8/28/2017 Oscillo: Flu-Like Symptoms* - visited on 8/28/2017 Page 2 of 4 - 1 + Categories: Back toShare 293 School Essentials, Cough, Cold and Flu, Branded Medicines. Tags: Body aches, Boiron, Chills, Fatigue, Fever, Flu-Like Symptoms, flu-relief, Headache, Homeopathy, Oscillo, Oscillococcinum. ABOUT VIDEO INGREDIENTS REVIEWS (0) WARNINGS & OTHER INFORMATION About Oscillo: Oscillococcinum reduces the duration and severity of flu-like symptoms, such as body aches, headache, fever, chills and fatigue.* Oscillococcinum does not cause drowsiness and has no known interactions with other medications. Its sweet-tasting pellets dissolve quickly under the tongue, no water, chewing or swallowing is required. Recommended for everyone ages 2 and up, Oscillococcinum works best when taken at the first sign of flu-like symptoms. Boiron is pleased to announce Oscillococcinum was recognized as the #1 pharmacist recommended brand in the “Homeopathic Flu Product” category by the U.S News & World Report and Pharmacy Times’ 2014 Survey of Pharmacists’ OTC Recommendations. Oscillo also received this award in 2010, 2011, 2012 and 2013.
    [Show full text]